1,3-dipropyl-8-cyclopentylxanthine has been researched along with Peripheral Nerve Diseases in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Morphine and R-PIA were administered to obtain the dose-response curve and the 50% effective dose (ED(50))." | 1.33 | Morphine can enhance the antiallodynic effect of intrathecal R-PIA in rats with nerve ligation injury. ( Cho, SK; Han, SM; Hwang, GS; Hwang, JH, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, JH | 1 |
| Hwang, GS | 1 |
| Cho, SK | 1 |
| Han, SM | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Morphine can enhance the antiallodynic effect of intrathecal R-PIA in rats with nerve ligation injury.
Topics: Adenosine A1 Receptor Agonists; Analgesics, Opioid; Animals; Circadian Rhythm; Dose-Response Relatio | 2005 |